stockrowNeurocrine Biosciences, Inc. (NBIX) vs Dr. Reddy's Laboratories Ltd (RDY)
- Neurocrine Biosciences, Inc. NBIX 164.51 +2.97%
- Dr. Reddy's Laboratories Ltd RDY 14.86 +2.27%
Neurocrine Biosciences, Inc. and Dr. Reddy's Laboratories Ltd are both Drug Manufacturers Specialty & Generic companies. Neurocrine Biosciences, Inc. is the larger, with a market value of $16.2B against $12.1B — 1.3× the size. Neurocrine Biosciences, Inc. trades at the lower P/E: 23.6× against 45.4×. Neurocrine Biosciences, Inc. grew revenue faster over the last twelve months: 38.0% against −15.5%. Neurocrine Biosciences, Inc. has the higher net margin (19.0% vs 8.06%) and the higher return on invested capital (17.7% vs 4.77%). Across the 22 metrics below, Neurocrine Biosciences, Inc. leads on 18 and Dr. Reddy's Laboratories Ltd on 4.
Valuation
Profitability
| Metric | NBIX | RDY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 97.78% | 49.16% | 53.51% |
| Operating margin | 23.96% | 9.20% | 0.00% |
| Net margin | 18.98% | 8.06% | (2.31%) |
| Free cash flow margin | 28.09% | 2.88% | 0.00% |
| Return on equity | 20.41% | 6.60% | (0.80%) |
| Return on assets | 14.20% | 4.44% | (1.67%) |
| Return on invested capital | 17.65% | 4.77% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack